Skip to main content
. 2021 Sep 8;24(4):624–638. doi: 10.1093/neuonc/noab210

Table 3.

Predictors of OS at Univariate and Multivariate Analyses

Variable Univariate Analysis Multivariate Analysis
Odds Ratio 95% CI P-value Odds Ratio 95% CI P-value
Age (yr) 1.017 0.977-1.058 .42
Sex
 Male 1 1
 Female 0.40 0.16-0.98 .045 0.22 0.14-0.88 .42
Tumor side
 Left 1
 Right 1.15 0.46-2.85 .80
Tumor site
 Frontal 1
 Parietal 1.74 0.48-6.38 .40
 Temporal 1.50 0.41-5.51 .50
 Insula 0.58 0.07-4.62 .60
Preoperative KPS 0.98 0.89-1.08 .70
Preoperative tumoral volume, cm3
Continuous variable
1..02 1.01-1.03 .001 1.03 1.01-1.05 .006
Preoperative tumoral volume, cm3
 0-15 1
 15-30 0.58 0.06-5.18 .60
 >30 4.47 1.44-13.8 .009
% EOR
Continuous variable
0.97 0.94-1.0 .037 0.95 0.90-1.01 .12
Postoperative RTV cm3
Continuous variable
1.03 1.00-1.06 .083
Postoperative RTV cm3
 Supratotal and complete resection 1 1
 RTV ≥1 cm3 2.93 1.00-8.60 .050 1.09 0.27-4.36 .95
Molecular class
 Oligodendroglioma 1
 Diffuse astrocitoma IDH1/2 mutated 2 0.74-5.43 .20
Early adjuvant treatment after surgery
 Yes vs No 0.99 0.67-5.43 .19

Abbreviations: CI, confidence interval; EOR, extent of resection; MRI, magnetic resonance imaging; P-value, level of marginal significance; RTV, residual tumor volume.

Table showing the influence of different factors on the OS rates as per univariate survival analysis and multivariate analysis (P < .05 at log-rank test). Bold values represent statistical significant results (P < .05). Tumor volume analysis was performed on 3D T2-FLAIR MRI. Patients belonging to IDH1/2 wild-type molecular class were not included in survival analysis because no deaths occurred in this subgroup.